118 related articles for article (PubMed ID: 37952808)
41. Multicenter Evaluation of Breast Cancer Screening with Digital Breast Tomosynthesis in Combination with Synthetic versus Digital Mammography.
Zuckerman SP; Sprague BL; Weaver DL; Herschorn SD; Conant EF
Radiology; 2020 Dec; 297(3):545-553. PubMed ID: 33048032
[TBL] [Abstract][Full Text] [Related]
42. Patterns of Screening Mammography and Breast MRI During the COVID-19 Pandemic: A Retrospective, Chart-Review Study.
Sivanushanthan S; Wu T; Wahl A; Li T; Luta G; Song JH; O'Neill S; Conley CC
J Breast Imaging; 2023; 5(3):277-286. PubMed ID: 37223455
[TBL] [Abstract][Full Text] [Related]
43. The COVID-19 Pandemic Impact on Breast Cancer Diagnosis: A Retrospective Study.
Negrao EMS; Cabello C; Conz L; Mauad EC; Zeferino LC; Vale DB
Rev Bras Ginecol Obstet; 2022 Sep; 44(9):871-877. PubMed ID: 35667376
[TBL] [Abstract][Full Text] [Related]
44. The New Coronavirus Pandemic and the Trend of Breast Cancer Diagnosis according to Age-Group: Total and Interrupted Time Series Study.
Hyeda A; Costa ÉSMD; Kowalski SC
Med Princ Pract; 2023; 32(2):117-125. PubMed ID: 36927744
[TBL] [Abstract][Full Text] [Related]
45. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic.
Lowry KP; Bissell MCS; Miglioretti DL; Kerlikowske K; Alsheik N; Macarol T; Bowles EJA; Buist DSM; Tosteson ANA; Henderson L; Herschorn SD; Wernli KJ; Weaver DL; Stout NK; Sprague BL
Radiology; 2022 May; 303(2):287-294. PubMed ID: 34665032
[TBL] [Abstract][Full Text] [Related]
46. Impact of the COVID-19 Pandemic on Histopathological Diagnosis of Breast Tumours in Calabar, Nigeria.
Udonkang M; Umoh N; Ogba O; Bebia G; Onwineng D; Anku B; Ernest N
Niger J Physiol Sci; 2023 Jun; 38(1):23-28. PubMed ID: 38243356
[TBL] [Abstract][Full Text] [Related]
47. The Impact of the COVID-19 Pandemic on Breast Imaging.
Freer PE
Radiol Clin North Am; 2021 Jan; 59(1):1-11. PubMed ID: 33222992
[TBL] [Abstract][Full Text] [Related]
48. Barriers To Accessing Contraception and Cervical and Breast Cancer Screening During COVID-19: A Prospective Cohort Study.
Baaske A; Brotto LA; Galea LAM; Albert AY; Smith L; Kaida A; Booth A; Gordon S; Sadarangani M; Racey CS; Gottschlich A; Ogilvie GS
J Obstet Gynaecol Can; 2022 Oct; 44(10):1076-1083. PubMed ID: 35738558
[TBL] [Abstract][Full Text] [Related]
49. An update on the status of breast cancer screening in Brazil after the covid-19 pandemic.
Bessa JF; Novita G; Freitas-Junior R
Rev Saude Publica; 2022; 56():88. PubMed ID: 36259913
[TBL] [Abstract][Full Text] [Related]
50. The trend and direct costs of screening and chemotherapy treatment of breast cancer in the new coronavirus pandemic: total and interrupted time series study.
Hyeda A; da Costa ÉSM; Kowalski SC
BMC Health Serv Res; 2022 Dec; 22(1):1466. PubMed ID: 36461119
[TBL] [Abstract][Full Text] [Related]
51. Imaging Utilization During the COVID-19 Pandemic Highlights Socioeconomic Health Disparities.
Naidich JJ; Boltyenkov A; Wang JJ; Chusid J; Rula E; Hughes D; Sanelli PC
J Am Coll Radiol; 2021 Apr; 18(4):554-565. PubMed ID: 33220184
[TBL] [Abstract][Full Text] [Related]
52. Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic.
Chan PS; Girotra S; Tang Y; Al-Araji R; Nallamothu BK; McNally B
JAMA Cardiol; 2021 Mar; 6(3):296-303. PubMed ID: 33188678
[TBL] [Abstract][Full Text] [Related]
53. Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
Blanchard K; Colbert JA; Puri D; Weissman J; Moy B; Kopans DB; Kaine EM; Moore RH; Halpern EF; Hughes KS; Tanabe KK; Smith BL; Michaelson JS
Cancer; 2004 Aug; 101(3):495-507. PubMed ID: 15274062
[TBL] [Abstract][Full Text] [Related]
54. Changes in breast cancer screening rates among 32 community health centers during the COVID-19 pandemic.
Fedewa SA; Cotter MM; Wehling KA; Wysocki K; Killewald R; Makaroff L
Cancer; 2021 Dec; 127(23):4512-4515. PubMed ID: 34436765
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
[TBL] [Abstract][Full Text] [Related]
56. Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis.
Bahl M; Mercaldo S; McCarthy AM; Lehman CD
Radiology; 2021 Feb; 298(2):308-316. PubMed ID: 33350890
[TBL] [Abstract][Full Text] [Related]
57. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
Tsibulak I; Reiser E; Bogner G; Petru E; Hell-Teutsch J; Reinthaller A; Weirather C; Weiss T; Bozsa S; Puschacher B; Hall M; Hittler D; Hrauda K; Thell E; Clauss S; Pozniak J; Alicke S; Gangl D; Gamperl G; Ebner C; Knoll K; Leitner K; Schilcher A; Schinnerl M; Sigl V; Singer C; Aigmüller T; Hofstätter B; Marth C
Int J Gynecol Cancer; 2020 Nov; 30(11):1667-1671. PubMed ID: 33033166
[TBL] [Abstract][Full Text] [Related]
58. Impact of the COVID-19 Pandemic on Health Care Utilization in a Large Integrated Health Care System: Retrospective Cohort Study.
Xu S; Glenn S; Sy L; Qian L; Hong V; Ryan DS; Jacobsen S
J Med Internet Res; 2021 Apr; 23(4):e26558. PubMed ID: 33882020
[TBL] [Abstract][Full Text] [Related]
59. Trends in Hospitalizations for Ambulatory Care-Sensitive Conditions During the COVID-19 Pandemic.
Becker NV; Karmakar M; Tipirneni R; Ayanian JZ
JAMA Netw Open; 2022 Mar; 5(3):e222933. PubMed ID: 35297972
[TBL] [Abstract][Full Text] [Related]
60. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
